189 related articles for article (PubMed ID: 28344178)
1. Systemic and Cerebral Concentration of Nimodipine During Established and Experimental Vasospasm Treatment.
Albanna W; Weiss M; Conzen C; Clusmann H; Schneider T; Reinsch M; Müller M; Wiesmann M; Höllig A; Schubert GA
World Neurosurg; 2017 Jun; 102():459-465. PubMed ID: 28344178
[TBL] [Abstract][Full Text] [Related]
2. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S
Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268
[TBL] [Abstract][Full Text] [Related]
3. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study.
Dehdashti AR; Binaghi S; Uske A; Regli L
Neurol India; 2011; 59(6):810-6. PubMed ID: 22234190
[TBL] [Abstract][Full Text] [Related]
4. Effect of Intra-Arterial and Intravenous Nimodipine Therapy of Cerebral Vasospasm After Subarachnoid Hemorrhage on Cerebrovascular Reactivity and Oxygenation.
Hockel K; Diedler J; Steiner J; Birkenhauer U; Ernemann U; Schuhmann MU
World Neurosurg; 2017 May; 101():372-378. PubMed ID: 28232152
[TBL] [Abstract][Full Text] [Related]
5. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
[TBL] [Abstract][Full Text] [Related]
6. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage.
Ott S; Jedlicka S; Wolf S; Peter M; Pudenz C; Merker P; Schürer L; Lumenta CB
Biomed Res Int; 2014; 2014():970741. PubMed ID: 24527461
[TBL] [Abstract][Full Text] [Related]
7. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
[TBL] [Abstract][Full Text] [Related]
8. Higher dose intra-arterial milrinone and intra-arterial combined milrinone-nimodipine infusion as a rescue therapy for refractory cerebral vasospasm.
Duman E; Karakoç F; Pinar HU; Dogan R; Fırat A; Yıldırım E
Interv Neuroradiol; 2017 Dec; 23(6):636-643. PubMed ID: 28956512
[TBL] [Abstract][Full Text] [Related]
9. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
Heffren J; McIntosh AM; Reiter PD
Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
[TBL] [Abstract][Full Text] [Related]
10. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
Bele S; Proescholdt MA; Hochreiter A; Schuierer G; Scheitzach J; Wendl C; Kieninger M; Schneiker A; Bründl E; Schödel P; Schebesch KM; Brawanski A
Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
[TBL] [Abstract][Full Text] [Related]
11. Endovascular therapy for vasospasm after aneurysmatic subarachnoid hemorrhage.
Kerz T; Boor S; Ulrich A; Beyer C; Hechtner M; Mueller-Forell W
Br J Neurosurg; 2016 Oct; 30(5):549-53. PubMed ID: 27080311
[TBL] [Abstract][Full Text] [Related]
12. Cerebral vasospasm and health-related quality of life after subarachnoid hemorrhage.
Tjahjadi M; König R; Wirtz CR; Woischneck D; Kapapa T
World Neurosurg; 2013; 80(1-2):113-20. PubMed ID: 23022640
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage.
Hui C; Lau KP
Clin Radiol; 2005 Sep; 60(9):1030-6. PubMed ID: 16124986
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Modeling of Intra-arterial Nimodipine Therapy for Subarachnoid Hemorrhage-Related Cerebral Vasospasm.
Seker F; Hesser J; Brockmann MA; Neumaier-Probst E; Groden C; Schubert R; Brockmann C
Clin Neuroradiol; 2017 Jun; 27(2):199-203. PubMed ID: 26350588
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
Hänggi D; Beseoglu K; Turowski B; Steiger HJ
Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
[TBL] [Abstract][Full Text] [Related]
16. Long-Term, Continuous Intra-Arterial Nimodipine Treatment of Severe Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
Hockel K; Diedler J; Steiner J; Birkenhauer U; Danz S; Ernemann U; Schuhmann MU
World Neurosurg; 2016 Apr; 88():104-112. PubMed ID: 26732964
[TBL] [Abstract][Full Text] [Related]
17. Effects of dose-response of topical administration of nimodipine on cerebral vasospasm after subarachnoid hemorrhage in rabbits.
Yin YH; Wang F; Pan YH; Wang Y; Wang Y; Luo QZ; Jiang JY
Am J Med Sci; 2009 Feb; 337(2):123-5. PubMed ID: 19214028
[TBL] [Abstract][Full Text] [Related]
18. Cisternal sustained release dihydropyridines for subarachnoid hemorrhage.
Cook DJ; Kan S; Ai J; Kasuya H; Macdonald RL
Curr Neurovasc Res; 2012 May; 9(2):139-48. PubMed ID: 22475399
[TBL] [Abstract][Full Text] [Related]
19. Continuous intra-arterial nimodipine infusion as rescue treatment of severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Anthofer J; Bele S; Wendl C; Kieninger M; Zeman F; Bruendl E; Schmidt NO; Schebesch KM
J Clin Neurosci; 2022 Feb; 96():163-171. PubMed ID: 34789415
[TBL] [Abstract][Full Text] [Related]
20. Continuous intra-arterial nimodipine for the treatment of cerebral vasospasm.
Mayer TE; Dichgans M; Straube A; Birnbaum T; Müller-Schunk S; Hamann GF; Schulte-Altedorneburg G
Cardiovasc Intervent Radiol; 2008; 31(6):1200-4. PubMed ID: 18446409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
